• Blog
  • Bone Graft and Substitute Market Growth Analysis | 2022-2028

    Bone Graft and Substitute Market Growth Analysis | 2022-2028

    Bone Graft and Substitute Market Growth Analysis | 2022-2028
    Report code - SR1571 Delivery - 2 Weeks
    Bone Graft and Substitute Market Size, Share, Trends, Dynamics, Forecast, & Growt See more...

    Market Insights

    The bone graft and substitute market was estimated at USD 3.05 billion in 2021 and is likely to grow at a CAGR of 6.24% during 2022-2028 to reach USD 4.69 billion in 2028.

    Bone-Graft-&-Substitute-Market-Size-Chart

    Want to know more about the market scope? Register Here

    What are bone grafts?

    Bone grafts are defined as implantable materials, which promote bone formation, bone healing, and osseous reconstruction due to their superior properties including osteogenic, osteoconductive, and osteoinductive. Bone grafts are also used to fill voids in case of the absence of bones.

    COVID-19 Impact

    The covid-19 outbreak posed significant challenges across verticals worldwide. It impacted the growth of the bone graft and substitute market negatively as the healthcare solutions other than covid-19 treatment declined due to fear of coronavirus infection. Also, supply chain disruptions due to the imposition of lockdown affected the product availability on time and thus, affected the market growth.

    Bone Graft and Substitute Market Highlights

    Market Size in 2028

    USD 4.69 Billion

    Market Size in 2021

    USD 3.05 Billion

    Market Growth (2022-2028)

    CAGR of 6.24%

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

    Key Players

    Key players operating in the bone graft and substitute market are-

    • Zimmer Biomet (US)
    • Medtronic plc (Ireland)
    • Aimedic MMT (Japan)
    • Dentsply Sirona (US)
    • DePuy Synthes (US)
    • Straumann (Switzerland)
    • Botiss medical AG (Germany)
    • Biomatlante (France)
    • Maxigen Biotech Inc. (Taiwan)
    • B. Braun (Germany)
    • BioMimetic Therapeutics, LLC (US)
    • CryoLife, Inc. (US)
    • Globus Medical, Inc. (US)
    • GRAFTYS (France)
    • Integra Life Sciences (US)
    • Johnson & Johnson (US).

    Market Dynamics

    The growth of the market is driven by following factors-

    • increasing incidences of musculoskeletal disorders across the globe
    • growing emphasis on the development of biocompatible synthetic bone grafts
    • surging demand for advanced products

    Bone-Graft-and-Substitute-Market-Snapshot

    Want to have a closer look at this market report? Click Here.

    Segment Analysis

    By Material Type

    The market has been bifurcated into Allografts, Synthetics, Other. allograft accounted for the largest share of more than 50% in 2021. Their properties, such as immediate structural support and osteoconductivity are the factors propelling the growth of the market for this segment.

    By Application Type

    The market is segmented into Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone & Spinal Fusion. Spinal fusion segment accounted for the largest share of more than 55% in 2021. The rising adoption of bone graft materials for spondylosyndesis & the rising geriatric population prone to orthopedic ailments are the major factors driving the growth of the segment.

    By End-Use Type

    The market has been bifurcated into hospitals and dental clinics. The hospital segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period. The segment can be attributed to the availability of required infrastructure, technical expertise, and skilled staff.

    Regional Analysis

    The North American market accounted for the largest market share of more than 35% in 2021 and is projected to grow at a robust CAGR during the review period. This can be attributed to the rising number of people suffering from orthopedic disorders coupled with expanding geriatric populace and the presence of key market players such as Zimmer Biomet (US) and Dentsply Sirona (US). The market growth in Asia-Pacific is expected to be driven by the increasing incidence of accidental injuries and rising medical tourism in developing countries.

    Bone-Graft-and-Substitute-Market-Regional-Analysis

    Know the high-growth countries in this report. Register Here.

    Scope & Segmentation

    The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    Report - Features

    Market Segmentation

    4

    Regions Covered

    5

    Countries/Sub-Regions Covered

    16

    No. of Figures & Tables

    >90

    Company Profiles

    16

     

    The market is segmented into the following categories:

    By Material Type

    • Allografts
    • Synthetics
    • Other

    By Application Type

    • Craniomaxillofacial
    • Dental
    • Foot & Ankle
    • Joint Reconstruction
    • Long Bone
    • Spinal Fusion

    By End-Use Type

    • Hospital
    • Dental Clinic

    By Region

    • North America
    • Europe
    • Asia-pacific
    • Middle East & Africa
    • South America

    Bone-Graft-and-Substitute-Market-Segments

    Click Here, to learn the market segmentation details.

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way and the structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Bone Graft and Substitute Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Target Audience

    Here is the list of the group of customers that the bone graft and substitute market hopes to have the greatest opportunity to convert-

    • Bone graft and substitute distributors
    • Bone graft and substitute suppliers
    • Bone graft and substitute manufacturers
    • Logistics organizations
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Recent Development

    Nov 2022: Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules

    Kuros Biosciences, a leader in next generation bone graft technologies, announced the completion of enrolment in the Level 1 clinical study, comparing MagnetOs Granules to the gold standard of autograft bone in patients undergoing posterolateral lumbar fusion.

    Oct 2022: Bioventus Showcased Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago

    Bioventus Inc., a global leader in innovations for active healing, presented its spine procedural solutions portfolio at the North American Spine Society (NASS) meeting in Chicago, October 12 through 15.

    Feb 2022: Bonalive® Biomaterials Ltd. granted FDA Breakthrough Device Designation for a bone graft substitute that potentially protects against microbial colonization

    The Center for Devices and Radiological Health at the Food & Drug Administration has determined that Bonalive® Orthopedics granules, made of a unique S53P4 bioactive glass, qualifies for designation as a Breakthrough Device.

    Frequently Asked Questions (FAQs)

    The bone graft & substitute market is expected to grow at 6.24% CAGR during 2022-2028.

    The bone graft & substitute market size was estimated USD 3.05 billion in 2021.

    The bone graft & substitute market size is expected to reach USD 4.69 billion in 2028.

    Zimmer Biomet (US), Medtronic plc (Ireland), Aimedic MMT (Japan), Dentsply Sirona (US), DePuy Synthes (US), Straumann (Switzerland), Botiss medical AG (Germany), Biomatlante (France), Maxigen Biotech Inc. (Taiwan), B. Braun (Germany), BioMimetic Therapeutics, LLC (US), CryoLife, Inc. (US), Globus Medical, Inc. (US), GRAFTYS (France), Integra Life Sciences (US), Johnson & Johnson (US) are among the key players in the market.

    North America accounted for the largest market share in 2021.

    Bone graft and substitute distributors, Bone graft and substitute suppliers, Bone graft and substitute manufacturers, Logistics organizations, Government bodies are the target audience in the market.

    Increasing incidences of musculoskeletal disorders across the globe, growing emphasis on the development of biocompatible synthetic bone grafts, surging demand for advanced products are some of the factors drives the market.

    Hospital segment accounted for the largest share in the market in 2021.